RESMED INC. COMMON STOCK

Study Estimates a 23% Increase in COPD by 2050, Representing 600 Million Patients Globally

07 Dec 2023 15:34:58 By Nasdaq GlobeNewswire

ResMed Adopts New Operating Model to Accelerate Long-term Growth

09 Nov 2023 16:05:02 By Nasdaq GlobeNewswire

ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2024

26 Oct 2023 16:05:00 By Nasdaq GlobeNewswire

ResMed to Report First Quarter Fiscal 2024 Earnings on October 26, 2023

05 Oct 2023 16:05:00 By Nasdaq GlobeNewswire

ResMed Announces Participation in Upcoming Conferences

05 Sep 2023 16:05:00 By Nasdaq GlobeNewswire

ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2023

03 Aug 2023 16:05:02 By Nasdaq GlobeNewswire

ResMed to Report Fourth Quarter Fiscal 2023 Earnings on August 3, 2023

06 Jul 2023 16:05:00 By Nasdaq GlobeNewswire

ResMed Acquires Somnoware, a Leader in Digital Sleep and Respiratory Care Diagnostics Software

05 Jul 2023 16:05:00 By Nasdaq GlobeNewswire

PAP Adherence Lowers ER Visits 24-36% in 1 Year for People with Sleep Apnea and Heart Failure: ResMed Studies Presented at SLEEP

08 Jun 2023 09:00:00 By Nasdaq GlobeNewswire

ResMed Announces Participation in the Goldman Sachs 44th Annual Global Healthcare Conference

05 Jun 2023 16:05:00 By Nasdaq GlobeNewswire

3 World-Renowned Sleep Apnea Experts Present New Benefits of PAP Therapies at ATS 2023

25 May 2023 09:00:01 By Nasdaq GlobeNewswire

ResMed Appoints Michael Rider its Next Global General Counsel, Dawn Haake its First Chief Quality Officer

02 May 2023 16:05:00 By Nasdaq GlobeNewswire

ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2023

27 Apr 2023 16:05:01 By Nasdaq GlobeNewswire

ResMed to Report Third Quarter Fiscal 2023 Earnings on April 27, 2023

06 Apr 2023 16:05:00 By Nasdaq GlobeNewswire

ResMed Chief Administrative Officer and Global General Counsel to Retire

30 Mar 2023 16:05:00 By Nasdaq GlobeNewswire

ResMed Announces Participation in the 2023 KeyBanc Life Sciences & MedTech Investor Forum

15 Mar 2023 16:19:09 By Nasdaq GlobeNewswire

ResMed’s Annual Global Sleep Survey Finds 8 in 10 Adults Experience Signs of Disruption Related to Their Quality of Sleep

13 Mar 2023 07:00:00 By Nasdaq GlobeNewswire

ResMed Announces Participation in the Oppenheimer 33rd Annual Healthcare Conference

07 Mar 2023 09:00:01 By Nasdaq GlobeNewswire

ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2023

26 Jan 2023 16:05:01 By Nasdaq GlobeNewswire

ResMed Appoints Michael Farrell as Chair of its Board of Directors Peter Farrell to Become Chair Emeritus

26 Jan 2023 16:05:00 By Nasdaq GlobeNewswire